UK-based Custom Pharma Services, a contract development and manufacturing organization (CDMO), has acquired a new building to expand its high containment manufacturing and development operations.

The new facility, the Custom Pharmaceutical Innovation Centre, is co-located on the Fairway Trading Estate in Brighton, adjacent to the company’s existing packaging and warehousing operations. Acquisition of this site will allow Custom Pharma Services to increase its capacity for clinical and product development of highly potent molecules and advance its commercial manufacturing capabilities with high containment capabilities to meet customer demand.

“Since 1979, Custom Pharma Services has provided solid dose manufacturing and development services. We offer our customers a full range of services, from clinical to commercial, including design of process and formulation development prototypes, stability and analytical testing, certification, contract manufacturing, primary packaging, shipment, consultancy and customer support,” said Nigel Richardson, chief executive officer, Custom Pharma Services.

“Later this year, we plan to commence work on the building. This expansion is a tremendous opportunity to consolidate our operations and concentrate on broadening our scope of services,” said Mr. Richardson. “Custom Pharma has earned a reputation for providing dependable customer support and innovative products. This is a big step, enabling us to deliver a wider range of services aligned with current industry requirements.”

Custom Pharma Services is exhibiting at CPhI in booth 3B48.